JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 21, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/29/20129    most recent
M601514200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryan, K. E.
Right arrow Articles by Rubenstein, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryan, K. E.
Right arrow Articles by Rubenstein, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 10, 2006
J. Biol. Chem, 10.1074/jbc.M601514200
Submitted on February 16, 2006
Revised on April 21, 2006
Accepted on May 10, 2006

Effects of human deafness gamma -actin mutations (DFNA20/26)on actin function

Keith E. Bryan, Kuo-Kuang Wen, Mei Zhu, Nanna Dahl Rendtorff, Michael Feldkamp, Lisbeth Tranebjaerg, Karen H. Friderici, and Peter A. Rubenstein

Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA 52242

Corresponding Author: peter-rubenstein{at}uiowa.edu

Six point mutations in non-muscle gamma -actin at the DFNA20/26 locus cause autosomal-dominant non-syndromic hearing loss. The molecular basis for the hearing loss is unknown. We have engineered each gamma -actin mutation into yeast actin to investigate the effects of these mutations on actin function in vivo and in vitro. Cells expressing each of the mutant actins as the sole actin in the cell were viable. Four of the six mutant strains exhibit significant growth deficiencies in complete media and an inability to grow on glycerol as a sole carbon source implying a mitochondrial defect(s). These four strains exhibit abnormal mitochondrial morphology although the mitochondrial DNA is retained. All of the mutant cells exhibit an abnormally high percentage of fragmented/non-polarized actin cables or randomly distributed actin patches. Five of the six mutants display strain-specific vacuole morphological abnormalities. Two of the purified mutant actins exhibit decreased thermal stability and increased rates of nucleotide exchange, indicative of increased protein flexibility. V370A actin alone polymerizes abnormally. It aggregates in low ionic strength buffer and polymerizes faster than WT actin, probably in part because of enhanced nucleation. Mixtures of WT and V370A actins display kinetic properties in proportion to the mole fraction of each actin in the mixture. No dominant effect of the mutant actin was observed. Our results suggest that a major factor in the deafness caused by these mutations is an altered ability for the actin filaments to be properly regulated by actin-binding proteins rather than an inability to polymerize.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.